Risk factors for variant Creutzfeldt-Jakob disease in dental practice: A case-control study

British Dental Journal

Volumn 213, Issue 11, 2012, Pages

  Molesworth, A M ^a   Smith, A J ^b   Everington, D ^a   Ord, F ^a   Watt, P ^a   Will, R G ^a   Ward, H J T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; CREUTZFELDT JAKOB DISEASE; CROSS INFECTION; DENTAL PROCEDURE; DENTISTRY; DISEASE TRANSMISSION; FEMALE; GENERAL PRACTICE; HEALTH SURVEY; HUMAN; MALE; MEDICAL RECORD; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CREUTZFELDT-JAKOB SYNDROME; CROSS INFECTION; DENTAL CARE; DENTAL RECORDS; FEMALE; GENERAL PRACTICE, DENTAL; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; STATE DENTISTRY; YOUNG ADULT;

EID: 84870934420     PISSN: 00070610     EISSN: 17417503     Source Type: Journal    
DOI: 10.1038/sj.bdj.2012.1089     Document Type: Article

References (31)

1. Health Protection Agency. Summary results of the second national survey of abnormal prion prevalence in archived appendix specimens. Health Protection Report 2012; 6(32). Available at http://www.hpa.org.uk/hpr/archives/2012/news. htm#32
2. Advisory Committee on Dangerous Pathogens (ACDP) TSE Risk Assessment Subgroup. Position statement on occurrence of vCJD and prevalence of infection in the UK population, July 2012. Online article available at https://www.wp.dh.gov.uk/transparency/files/2012/08/ACDP-statement-vCJD- occurrence-and-prevalence-Jul-2012.pdf
3. Ward H J, Everington D, Cousens S N et al. Risk Factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006; 59: 111-120.
4. Llewelyn C A, Hewitt P E, Knight R S et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421.
5. Peden A H, Head M W, Ritchie D L, Bell J E, Ironside J W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-529.
6. Kurita H, Kurashina K, Honda T. Nosocomial transmission of methicillin resistant Staphylococcus aureus via the surfaces of the dental operatory. Br Dent J 2006; 201: 297-300.
7. Redd J T, Baumbach J, Kohn W, Nainan O, Khristova M, Williams I. Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis 2007; 195: 1311-1314.
8. Ironside J W, McCardle L, Horsburgh A, Lim Z, Head M W. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002; 110: 79-87.
9. Head M W, Ritchie D, McLoughlin V, Ironside J W. Investigation of PrPres in dental tissues in variant CJD. Br Dent J 2003; 195: 339-343.
10. World Health Organization. WHO tables on tissue infectivity distribution in transmissible spongiform encephalopathies. Geneva: WHO, 2010.
11. Ingrosso L, Pisani F, Pocchiari M. Transmission of the 263K scrapie strain by the dental route. J Gen Virol 1999; 80: 3043-3047.
12. Bartz J C, Kincaid A E, Bessen R A. Rapid prion neuroinvasion following tongue infection. J Virol 2003; 77: 583-591.
13. Mathiason C K, Powers J G, Dahmes S J et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 2006; 314: 133-136.
14. Bartolucci E G. A clinical evaluation of freeze dried homologous dura mater as a periodontal free graft material. Study in humans. J Periodontol 1981; 52: 354-361.
15. Wenz B, Oesch B, Horst M. Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine bone. Biomaterials 2001; 22: 1599-1606.
16. Smith A, Dickson M, Aitken J, Bagg J. Contaminated dental instruments. J Hosp Infect 2002; 51: 233-235.
17. NHS Scotland, Sterile Services Provision Review Group. Survey of decontamination in general dental practice. Scottish Executive Health Department, 2004.
18. Bagg J, Smith A J, Hurrell D, McHugh S, Irvine G. Pre-sterilisation cleaning of re-usable instruments in general dental practice. Br Dent J 2007; 202: E22.
19. Economics and Operational Research Division. Potential vCJD transmission risks via dentistry: an interim review. London: DH, 2007.
20. Department of Health. The dental national decontamination survey 2010. London: DH, 2010.
21. Vassey M, Budge C, Poolman T et al. A quantitative assessment of residual protein levels on dental instruments reprocessed by manual, ultrasonic and automated cleaning methods. Br Dent J 2011; 210: E14.
22. Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek D C. Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985; 35: 1483-1486.
23. Van Duijin C M, Delasnerie-Laupretre N, Masullo C et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 1988; 351: 1081-1085.
24. Collins S, Law M G, Fletcher A, Boyd A, Kaldor J, Masters C L. Surgical treatment and risk of sporadic Creutzfeldt-Jacob disease: a case control study. Lancet 1999; 353: 693-697.
25. Everington D, Smith A J, Ward H J, Letters S, Will R G, Bagg J. Dental treatment and risk of vCJD-case control study. Br Dent J 2007; 202: E19.
26. National CJD Surveillance Unit. Creutzfeldt-Jakob Disease surveillance in the UK: 18th annual report 2009. Edinburgh: The National CJD Research and Surveillance Unit, 2011.
27. National CJD Surveillance Unit. National CJD surveillance diagnostic criteria. Edinburgh: The National CJD Research and Surveillance Unit, 2010.
28. Department of Health. Management of possible exposures to CJD through medical procedures. London: DoH, 2001.
29. Molesworth A M, Cousens S N, Noel G O, Ward H J. Variant Creutzfeldt-Jakob disease in the United Kingdom: a countrywide or local risk? J Epidemiol Community Health 2010; 64: 616-621.
30. Burnie R, Salmon R L, Thomas D R, Monaghan N. Does poor dental health have a role in the emergence of variant Creutzfeldt Jakob disease in the United Kingdom? J Dental Hypotheses 2011; 2: 74-82.
31. Advisory Committee on Dangerous Pathogens (ACDP). Transmissible spongiform encephalopathy agents: safe working and the prevention of infection: part 4. Infection control of CJD, vCJD and other human prion diseases in healthcare and community settings. London: Department of Health, 2011. Online article available at http://www.dh.gov.uk/ab/ACDP/TSEguidance/index.htm (accessed November 2012).